INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 427m ago
House PTR27m ago
SEC 13F26m ago
Robinhood Chain26m ago

Results

77,289 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,858 sh
Apr 30, 2026Apr 30, 2026
Page 1054 of 1933
← PrevNext →
traded Apr 30, 2026
+0d
SEC Form 4

Evidence

5
BJ
Ball Robert JosephDirector, CEO & Executive Chairman
SISHOULDER INNOVATIONS, INC.
Option exercise
M—
10.0K sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
BJ
Ball Robert JosephDirector, CEO & Executive Chairman
SISHOULDER INNOVATIONS, INC.
Option exercise
M$25K
10.0K sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
LL
Ladd Amy LDirector
ISRGINTUITIVE SURGICAL INC
Grant or award
A—
554 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
LL
Ladd Amy LDirector
ISRGINTUITIVE SURGICAL INC
Option exercise
M—
531 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

5
MT
Mark & Robyn Jones Descendants Trust 201410% Owner, Member of 10% owner group
GSHDGoosehead Insurance, Inc.
Derivative conversion
C—
5,307 sh
Apr 29, 2026Apr 30, 2026
traded Apr 29, 2026
+1dSEC Form 4

Evidence

5
MT
Mark & Robyn Jones Descendants Trust 201410% Owner, Member of 10% owner group
GSHDGoosehead Insurance, Inc.
Derivative conversion
C—
5,307 sh
Apr 29, 2026Apr 30, 2026
traded Apr 29, 2026
+1dSEC Form 4

Evidence

5
MT
Mark & Robyn Jones Descendants Trust 201410% Owner, Member of 10% owner group
GSHDGoosehead Insurance, Inc.
Derivative conversion
C—
5,307 sh
Apr 29, 2026Apr 30, 2026
traded Apr 29, 2026
+1dSEC Form 4

Evidence

2
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise
M—
2,000 sh
Apr 30, 2026Apr 30, 2026
traded Apr 30, 2026
+0dSEC Form 4

Evidence

2
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
19.2K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

2
FJ
Fredman Sheara JChief Accounting Officer
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
14.2K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

2
Ruemmler Kathryn H.Chief Legal Officer, GC
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
27.1K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

1
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$93K
1,875 sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
107.7K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
107.7K sh
Apr 28, 2026Apr 30, 2026
traded Apr 28, 2026
+2dSEC Form 4

Evidence

53
JR
Jeffrey John Ronald Jr.Director
AGXARGAN INC
Open-market sale
SELL$1.79M
2,698 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.42M
12.7K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
SI
Simonsson Beatrice IngmarieChief Digital Officer
PSNYPolestar Automotive Holding UK PLC
Open-market sale
SELL$9,319
527 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.69M
15.1K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
EH
Engstrom Jonas HakanChief Operating Officer
PSNYPolestar Automotive Holding UK PLC
Open-market sale
SELL$22K
1,250 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
DF
Dicken Scott FraserChief Commercial Officer
PSNYPolestar Automotive Holding UK PLC
Open-market sale
SELL$16K
895 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
RM
Rudensjo Anna Elin MargaretaChief Legal Officer
PSNYPolestar Automotive Holding UK PLC
Open-market sale
SELL$25K
1,387 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
HJ
Henricsson Nina JosefinChief Human Resources Officer
PSNYPolestar Automotive Holding UK PLC
Open-market sale
SELL$2,688
152 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
Scott H. PetersDSpouse
UBU.S Treasury Bills
Purchase
BUY$500K – $1.00MMar 25, 2026Apr 29, 2026
traded Mar 25, 2026
+35dHouse PTR

Evidence

44
HT
Hannigan ToddDirector, Executive Chairman
IPXIPERIONX Ltd
Open-market purchase
BUY$1.09M
260.0K sh
Apr 29, 2026Apr 29, 2026
traded Apr 29, 2026
+0dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$7.86M
70.5K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.97M
17.6K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

43
FW
Fox David W JrEVP & Chief Financial Officer
NTRSNORTHERN TRUST CORP
Open-market sale
SELL$3.32M
20.0K sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC Form 4

Evidence

42
FL
Fink LaurenceDirector, Chairman and CEO
BLKBlackRock, Inc.
Open-market sale
SELL$14.53M
13.8K sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$874K
7,845 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$328K
2,941 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

41
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$422K
3,764 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$307K
2,741 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$874K
7,844 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC Form 4

Evidence

41
HT
Hannigan ToddDirector, Executive Chairman
IPXIPERIONX Ltd
Open-market purchase
BUY$986K
220.0K sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC Form 4

Evidence

40
Scott H. PetersDSpouse
UBU.S Treasury Bills
Purchase
BUY$250K – $500KMar 30, 2026Apr 29, 2026
traded Mar 30, 2026
+30dHouse PTR

Evidence